Previous Article | Next Article 
Molecular and Cellular Biology, February 2000, p. 842-850, Vol. 20, No. 3
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Dynamic Analysis of Proviral Induction and De Novo Methylation:
Implications for a Histone Deacetylase-Independent, Methylation
Density-Dependent Mechanism of Transcriptional Repression
Matthew C.
Lorincz,1,*
Dirk
Schübeler,1
Scott C.
Goeke,1
Mark
Walters,1
Mark
Groudine,1,2 and
David I. K.
Martin1,
Fred Hutchinson Cancer Research
Center1 and Department of Radiation
Oncology, University of Washington School of
Medicine,2 Seattle, Washington
Received 31 August 1999/Returned for modification 22 October
1999/Accepted 28 October 1999
 |
ABSTRACT |
Methylation of cytosines in the CpG dinucleotide is generally
associated with transcriptional repression in mammalian cells, and
recent findings implicate histone deacetylation in methylation-mediated repression. Analyses of histone acetylation in in vitro-methylated transfected plasmids support this model; however, little is known about
the relationships among de novo DNA methylation, transcriptional repression, and histone acetylation state. To examine these
relationships in vivo, we have developed a novel approach that permits
the isolation and expansion of cells harboring expressing or silent
retroviruses. MEL cells were infected with a Moloney murine leukemia
virus encoding the green fluorescent protein (GFP), and single-copy,
silent proviral clones were treated weekly with the histone deacetylase
inhibitor trichostatin A or the DNA methylation inhibitor
5-azacytidine. Expression was monitored concurrently by flow cytometry,
allowing for repeated phenotypic analysis over time, and proviral
methylation was determined by Southern blotting and bisulfite
methylation mapping. Shortly after infection, proviral expression was
inducible and the reporter gene and proviral enhancer showed a low
density of methylation. Over time, the efficacy of drug induction
diminished, coincident with the accumulation of methyl-CpGs across the
provirus. Bisulfite analysis of cells in which 5-azacytidine treatment
induced GFP expression revealed measurable but incomplete demethylation of the provirus. Repression could be overcome in late-passage clones
only by pretreatment with 5-azacytidine followed by trichostatin A,
suggesting that partial demethylation reestablishes the
trichostatin-inducible state. These experiments reveal the presence of
a silencing mechanism which acts on densely methylated DNA and appears
to function independently of histone deacetylase activity.
 |
INTRODUCTION |
Transcriptional repression of
heterologous genetic elements such as proviruses is often observed
concomitantly with their integration and packaging into chromatin in
the host cell genome (57). Transcriptional activity is
negatively influenced in cis by deacetylation of nucleosomal
histones (4, 54, 56) and methylation of cytosines (22,
29, 45, 55), particularly in the dinucleotide 5'CpG
(cytosine-guanine). Transfection of in vitro-methylated constructs
reveals a clear relationship between methylation density and
transcriptional repression (6, 27). While the repression
associated with methylated DNA is known to require a chromatin template
(8, 31) and involve a condensed chromatin structure
(32), the mechanism underlying this alteration remained
unresolved until recently. The description of a biochemical association
between the transcriptional-repression domain (TRD/MRD) of the
methyl-CpG (mCpG)-binding protein MeCP2 and a corepressor complex
containing histone deacetylases (HDACs) suggests that mCpGs
suppress transcription by recruiting HDACs which deacetylate chromatin in cis (30, 43). Chromatin
immunoprecipitation experiments lend further support to this model: in
contrast to an unmethylated reporter gene, stable transfection of an
identical but in vitro-methylated construct reveals no preferential
association with acetylated nucleosomal fractions (17).
However, failure of the extremely potent histone deacetylase inhibitor
trichostatin A (TSA) (60) to fully reactivate
TRD/MRD-mediated repression (30, 43), as well as a report of
repression mediated by the MeCP2 methyl-CpG binding domain (MBD) alone
(34) suggests that MeCP2-mediated repression may also
involve acetylation-independent mechanisms. Furthermore, the recent
description of several novel proteins with MBDs demonstrates that
additional factors may play a role in methylation-mediated repression
(15, 24).
Experiments involving in vitro methylation and a stable episomal
reporter demonstrate that transcriptional activity and induction with
the nonspecific HDAC inhibitor sodium butyrate are inversely dependent
on methylation density (27). Similarly, a mutant
FMR1 gene harboring an expanded, hypermethylated CGG repeat
is refractory to TSA-mediated transcriptional induction
(14). Recently, Cameron et al. (10) showed that
several densely methylated endogenous genes could be reactivated only
by treatment with 5-azacytidine (5-azaC) followed by TSA and proposed,
based on these results, that CpG methylation and histone deacetylation
act synergistically to silence CpG island-containing genes. While TSA
has been shown to induce the expression of integrated viruses (11,
56), the relationships among methylation density, histone
deacetylation, and expression of proviral sequences have yet to be
addressed. In this study, we used a green fluorescent protein
(GFP)-based retroviral reporter system (1) to assess the
dynamic relationship between proviral induction, de novo methylation,
and histone acetylation. In contrast to conventional drug selection,
this fluorescence-activated cell sorter (FACS)-based assay permits the
isolation and expansion of expressing or nonexpressing subpopulations
for further analysis. Furthermore, while transfection or microinjection
studies of in vitro-methylated DNA provide a static picture of the
influence of DNA methylation (6, 27, 42), the proviral
template characterized here is integrated in the host genome and
progressively methylated de novo. Consequently, we believe that this
system more accurately reflects the native process of
mCpG-associated transcriptional repression of foreign genetic
elements (52).
We generated MEL cell clones with single-copy proviral integrants in
which expression could be induced by TSA. At weekly intervals after
infection, subcultures of these clones were treated with TSA or the
cytidine analog 5-azaC (22), which inhibits DNA methylation, and proviral expression was monitored by FACS analysis. Proviral methylation status was simultaneously measured by Southern analysis and
the bisulfite sequencing method. Surprisingly, in the majority of
clones analyzed, a progressive diminution of drug-inducible expression
was observed coincident with an increase in proviral methylation. Under
the conditions used, the provirus was only partially demethylated in
the presence of 5-azaC, yielding a methylation density comparable to
that seen in earlier-passage TSA-inducible cells. In late-passage
clones, the provirus was densely methylated and transcriptional
repression was relieved by pretreatment with 5-azaC followed by TSA,
but not with either drug alone, results consistent with those recently
reported for several hypermethylated endogenous genes (10).
These experiments reveal the dynamic nature of DNA methylation and
associated transcriptional repression and suggest that while repression
of nascent provirus bearing a low level of methylation is mediated
primarily by HDAC activity, late-passage highly methylated proviral DNA
appears to be repressed by an HDAC-independent mechanism.
 |
MATERIALS AND METHODS |
Retroviral infections.
To generate a GFP gene optimized for
flow cytometric analysis, a "humanized" GFP gene
(hGFP) (optimized for translational efficiency in mammalian
cells [23]) was mutated to improve stability and
fluorogenic properties (reference 1 and data not
shown), yielding hGFP-Bex1. This GFP variant was cloned
between the NcoI and BamHI sites of the Moloney
murine leukemia virus (M-MuLV) vector MFG (16), yielding the
retroviral vector MFG-hGFP. High-titer MFG-hGFP
retrovirus was generated by calcium phosphate transfection of Phoenix A
retroviral producer cells as described previously (25).
Retroviral supernatant was added to 5 × 104 MEL
(745-A) cells cultured in log phase in 2 ml of growth medium (RPMI 1640 medium supplemented with 10% bovine calf serum, 100 U of penicillin
per ml, 0.05 mM streptomycin, and 2 mM glutamine). To maximize
infection efficiency (3), the cell suspension-retroviral supernatant mix was supplemented with 5 µg of Polybrene per ml and
centrifuged at 2,000 rpm for 1 h at room temperature. The cells
were harvested 7 h later, washed, resuspended in Polybrene-free growth medium, and cultured under standard laboratory conditions. The
MEL MFG-hGFP clones were derived as described in the legend to Fig. 1. Cells were maintained in log-phase growth for all experiments.
TSA and 5-azaC treatment, FACS analysis, and cell sorting.
Preliminary experiments with TSA revealed that both cytotoxicity and
proviral expression increase in a dose-dependent manner (data not
shown). In all experiments, 100 nM TSA was used, a concentration which
yielded maximal induction while minimizing cytotoxicity; >90% of
cells were viable as measured by propidium iodide (PI) staining. For
each experiment, aliquots of TSA (Wako Pure Chemical Industries, Ltd.)
(dissolved at 5 mg/ml in methanol and stored at
20°C) were thawed,
diluted in fresh growth medium, and immediately added to MEL cells.
Aliquots of 5-azaC (Sigma) (1.2 mg/ml in water) were added at a final
concentration of 5 µM (58). Cells were harvested 24 h
after addition of TSA and/or 5-azaC, unless otherwise indicated. Prior
to analysis, single-cell suspensions were centrifuged at
1,200 × g for 5 min and washed with staining medium
(phosphate-buffered saline supplemented with 3% [vol/vol] fetal calf
serum). Cells were resuspended in staining medium supplemented with
propidium iodide (PI) (1 µg/ml, final concentration) for live-dead
discrimination. FACS analyses and cell sorting were carried out on
FACSCalibur and FACS Vantage (Becton Dickinson) cytometers,
respectively, both equipped with the standard fluorescein filter set.
Multiparameter data were analyzed by using the FlowJo analysis package
(Tree Star Inc.). Data on a minimum of 10,000 live cells were collected for each sample. For cell sorting, electronic gates were established to
exclude dead cells on the basis of light scatter and PI fluorescence.
Southern blot hybridization and methylation blotting.
Preparation of high-molecular-weight genomic DNA, restriction digests,
membrane transfers, and preparation of the DNA probe were performed by
standard methods (50). The GFP probe used for Southern
hybridization was generated by digestion of the MFG-hGFP plasmid with NcoI and BamHI, yielding a
restriction fragment including the 720-bp hGFP gene.
Single-copy integrants were identified by digestion of genomic DNA with
BamHI, which cuts once in the MFG-hGFP provirus,
followed by Southern blot analysis with the GFP probe. The methylation
status of the hGFP gene was determined by digestion of 20 µg of genomic DNA with BamHI and the methylation-sensitive enzyme HpaII or, as a control, the methylation-insensitive
isoschizomer MspI. The methylation status of the 5' long
terminal repeat (LTR) was determined by digestion with BamHI
and the methylation-sensitive enzyme BssHII. The restriction
fragments were quantitated by PhosphorImager (Molecular Dynamics)
analysis, which revealed a weak nonspecific band that comigrated with
the BssHII-BamHI fragment. To correct for the
contribution of this nonspecific band in the quantitative analyses, the
fraction of comigrating DNA in the BamHI-alone lane was
subtracted from the total DNA value and the fraction of DNA resistant
to BssHII digestion in each sample was divided by the resulting value. The nonspecific band represented a maximum of 10% of
the DNA in each lane.
Sodium bisulfite treatment.
The bisulfite conversion was
carried out, with minor modifications, by the method developed by Clark
et al. (13). Genomic DNA was linearized with
BamHI, phenol-chloroform extracted, and ethanol
precipitated. For the time course study, 100 ng of digested DNA was
mixed with 2 µg of tRNA as carrier and denatured by adding freshly
prepared NaOH to a final concentration of 0.3 M in a 20-µl reaction
volume and incubating the mixture at 42°C for 30 min. For the
cell-sorting experiment, 5,000 sorted viable cells were resuspended in
a proteinase K (40 µg/ml, final concentration)-sodium dodecyl
sulfate (1.6%, final concentration) solution and denatured as for the
genomic DNA. Fresh solutions of sodium bisulfite (Sigma), adjusted to
pH 5 with NaOH, and hydroquinone (Sigma) were prepared and added to the
denatured DNA at final concentrations of 3.4 M and 1 mM, respectively,
in a final volume of 100 µl. DNA solutions were gently mixed,
overlaid with mineral oil, and incubated at 55°C for 8 to 16 h.
Unreacted bisulfite was removed by spin column chromatography
(MicroSpin sephacryl S-200 HR; Amersham) as recommended by the
manufacturer. Purified DNA samples (equilibrated in Tris-EDTA [TE]
buffer) were mixed with NaOH at a final concentration of 0.3 M and
incubated at 37°C for 20 min. The desulfonated samples were
neutralized on an S-200 HR column, and the flowthrough fraction (~100
µl) containing the converted DNA was stored at
20°C.
PCR amplification, cloning, and sequence analysis.
Reaction
mixtures containing 5 µl of bisulfite-treated DNA (50 µl final vol)
were subjected to 25 to 32 amplification cycles with a GeneAmp PCR
system 9700 (Perkin-Elmer), with denaturation at 94°C, annealing at
49 to 56°C and extension at 72°C. Nested or seminested
amplification was performed with 2 µl of product from the first round
in a 50-µl reaction mixture. Primers were designed to favor the
amplification of bisulfite-converted DNA. If the template strand
included a CpG, degeneracy was incorporated into the primer at the
nucleotide position corresponding to the cytosine such that no bias for
amplification of methylated template was introduced. For analysis of
the methylation state of the plus strand of the M-MuLV 5' LTR, the
primers used in the first round were +25+
(TAGGTTTGGTAAGTTAGTTTAAGTAAYGTT) (where Y is thymosine or
cytidine) and +1080
(TAAAAAAATAATAACAAACTAACCCRAAC) (where R is adenosine or guanosine) and the primers used in the second round
were +58+ (TTGTAAGGTATGGAAAAATATATAATTG) and +665
(TAAATTACTAACCAACTTACCTCCCRATAA). For analysis of the
methylation state of the plus strand of the GFP gene, the primers used
in the first round were +1870+ (ATTATTTTTTAGATTGTTATGGTGAGTAAGGG) and +2300
(CTCAAGCTTATAATTATACTCCAACTTATACCCCA) and
the primers used in the second round were +1903+
(GAGGAGTTGTTTATYGGGGTGGTGTTT) and +2300
. Amplification
products were directly purified by using the Qiaquick PCR purification
kit (Qiagen) or subjected to electrophoresis in 1.5% Tris-acetate-EDTA
(TAE) agarose gels and purified by using the Qiaquick gel extraction
kit (Qiagen). The purified amplification products were ligated into
plasmid p-GEM-T Easy by using the p-GEM-T Easy vector system (Promega)
and transformed into competent Escherichia coli XL-1 Blue by
the CaCl2 method. Colonies were screened on the basis of
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal)
staining, and plasmid DNA was prepared by the alkali lysis method.
Plasmid clones harboring inserts of the appropriate size, as measured
by restriction analysis, were amplified with the SP6 promoter primer
and the ABI PRISM Dye Terminator cycle sequencing ready-reaction kit
and sequenced with an ABI PRISM 377 DNA sequencer (Perkin-Elmer).
Sequence analyses were conducted with the Sequencher sequence analysis
package (Gene Codes Corporation), and sequence data from
bisulfite-treated DNA was compared to the vector sequence generated
with nonconverted template DNA. Each plasmid clone represents a single
"allelic" variant of the original clonal population. The sample
mean value of mCpGs for each genomic sample was determined by summing
the number of mCpGs determined for each allele and dividing by the
total number of alleles sequenced. The standard error of the mean (SEM)
is given for each allelic population. Statistical significance was
determined by using the unpaired two-sample t test assuming
unequal variance. Two-tailed P values are presented.
 |
RESULTS |
TSA- and 5-azaC-induced proviral expression decreases with time in
culture.
Infection of MEL cells with the M-MuLV-based vector
MFG-hGFP (Fig. 1A) yielded a
subpopulation of infected cells harboring silenced proviral integrants
(Fig. 1B and C, lane 3), reflecting the presence of integration sites
which do not support expression (26, 28). These GFP-negative
cells were sorted and, to isolate the subpopulation of proviral
integrants inducible with TSA, subjected to two consecutive rounds of
TSA treatment and FACS sorting of GFP-positive cells. The TSA-inducible
cells were cloned by limiting dilution and screened for proviral copy
number by Southern blotting (Fig. 1C). Six single-copy TSA-inducible
proviral clones (clones 5, 6, 11, 18, 19, and 21) were serially
passaged in log-phase growth. At weekly intervals, subcultures of each
clone were treated with TSA or the methylation inhibitor 5-azaC,
previously shown to demethylate and activate M-MuLV proviral integrants
(26, 44, 53). After 24 h of treatment, the cells were
harvested and analyzed for GFP expression by FACS. Untreated cells were also harvested for analysis of proviral DNA methylation (Fig. 1B).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 1.
The MFG-hGFP vector and strategy for
generating TSA-inducible MEL clones. (A) The 720-bp hGFP
gene was inserted downstream of the splice acceptor site (SA) in the
MFG retroviral vector. Transcriptional regulation of hGFP is
mediated by the 5' LTR promoter-enhancer ( , packaging signal; SD,
splice donor). (B) MEL cells were infected with MFG-hGFP as
described in Materials and Methods. At 5 days p.i. (d.p.i.), 5 × 104 GFP-negative cells were sorted from the infected
population (Top filled histogram, with sort gate). The sorted negative
cells were treated with TSA at 9 days p.i., and GFP-positive cells were
sorted from this population on day 10. The majority of cells in this
pool of TSA-inducible cells became silent by day 16, at which time the
cells were treated again with TSA (bottom filled histogram), and
GFP-positive cells were sorted on day 17. These TSA-responsive cells
were cloned by limiting dilution at 25 days p.i. Of 24 clones analyzed,
10 showed very low to undetectable levels of spontaneous GFP
expression. Beginning at 34 days p.i., subcultures of six of these
clones (clones 5, 6, 11, 18, 19, and 21) were harvested weekly for
analysis of TSA and 5-azaC inducibility, as measured by FACS, and for
methylation status, as measured by Southern blotting and bisulfite
analysis. Unfilled histograms show the fluorescence distributions of
uninfected MEL cells. (C) The proviral copy number was determined by
Southern blotting with an hGFP probe. Each of the
clones chosen for further analysis (underlined) harbors a single
MFG-hGFP provirus at a unique integration site (lanes: MEL,
uninfected cells; sort, infected MEL cells sorted 5 days p.i.; TSA
sort, infected pool immediately prior to cloning).
|
|
FACS analysis revealed a progressive diminution of TSA and 5-azaC
induction with time in culture. Figure 2A
shows a representative clone (clone 5) in which TSA induced GFP
expression in more than 60% of viable cells 34 days postinfection
(p.i.) while fewer than 2% responded 88 days p.i. A summary of the
data collected for each clone reveals a clear time-dependent decrease
in both spontaneous and inducible GFP expression, with TSA and 5-azaC
inducibility being greatly diminished or entirely extinguished by day
88 p.i. (Fig. 2B). A similar diminution of responsiveness was
detected when the clones were treated with sodium butyrate (reference
48 and data not shown). Comparison of the TSA and
5-azaC results revealed a clear correlation between TSA and 5-azaC
responsiveness; for clones 5, 6, 18 and 19, a higher percentage of
cells responded to either drug than did the cells of clones 11 and 21. This correlation reveals that the same position effect may influence
the rate at which proviruses become refractory to TSA- and
5-azaC-mediated induction.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 2.
Induction of GFP expression by TSA and 5-azaC declines
over time. MEL MFG-hGFP clones were generated as described
in the legend to Fig. 1 and cultured in log phase. Aliquots were
removed weekly and treated with 100 nM TSA or 5 µM 5-azaC for 24 h. Electronic gating in the PI staining and forward- and side-scatter
channels was applied to exclude dead cells. The induction experiments
were initiated 34 days p.i. (d.p.i.) because of the time required to
derive TSA-responsive clones. (A) TSA-treated and untreated samples
from clone 5 assayed on successive days p.i., displayed as 5%
probability contour plots of GFP fluorescence versus forward scatter.
Note that in early-passage cultures, a small subpopulation of untreated
cells spontaneously express low levels of GFP. (B) At each time point,
an electronic gate in the GFP channel was applied (e.g., the dashed
line on day 34 in panel A), as established by gating on uninfected MEL
cells (data not shown), such that >99% of viable cells were excluded.
The percentages of viable GFP-positive cells in the absence of drug or
in the presence of TSA or 5-azaC at successive time points following
retroviral infection are shown.
|
|
Diminution of drug-induced expression is strongly correlated with
de novo methylation of the GFP gene and the 5' LTR.
TSA and 5-azaC
are believed to induce expression by counteracting the repressive
affect of methylation, the former by inhibiting associated HDAC
activity (17, 30, 43) and the latter by inhibiting
methylation of newly synthesized DNA (22, 44). To study the
relationship between de novo methylation and transcriptional induction
in the clones characterized above, the methylation state of the
provirus was studied in detail. Genomic DNA isolated weekly from
untreated subcultures was subjected to Southern blotting, which allows
rapid analysis of multiple samples but is limited to
methylation-sensitive restriction enzyme sites, and bisulfite genomic
sequencing, which allows the detection of any methylated cytosine.
Preliminary analysis of de novo methylation of the hGFP gene
was carried out with the methylation-sensitive enzyme HpaII
(Fig. 3A). Digestion and Southern
blotting of genomic DNA isolated during the course of the TSA and
5-azaC induction experiments revealed that the fraction of methylated
HpaII sites within the hGFP gene was initially
low but increased with time in three of the four clones (clones 6, 11, and 18) analyzed (Fig. 3B, graph). Clone 19, which appears to be
methylated at a lower rate, also maintained the highest residual TSA
and 5-azaC responsiveness (Fig. 2B). To characterize the methylation
density of the hGFP coding region at higher resolution,
genomic DNA isolated 39 and 78 days p.i. was analyzed by bisulfite
analysis (13, 19). Under the appropriate conditions, sodium
bisulfite catalyzes the conversion of cytosine to uracil whereas
5-methylcytosine is unreactive. PCR with strand-specific primers yields
a product in which uracil residues are amplified as thymine while
5-methylcytosine residues are amplified as cytosine. By cloning and
sequencing these PCR products, the methylation status of all cytosines
in the template strand can be determined.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
Change in methylation state of the hGFP gene
and the proviral LTR over time. (A) The
MspI-HpaII (H) and BssHII
sites in the MFG-hGFP provirus are shown in relation to the
5' LTR and hGFP gene. The schematic diagram also shows the
expected fragments if digestion with HpaII or
BssHII is not inhibited (*) or is partially inhibited by
methylation. Total genomic DNA was prepared weekly from the untreated
MEL MFG-hGFP clones. Digested fragments were separated by
electrophoresis on a 0.7% agarose gel, Southern blotted, and
hybridized with the hGFP probe. (B) Genomic DNA from clones
6, 11, 18, and 19 was digested with BamHI and either
HpaII (H) or its methylation-insensitive isoschizomer,
MspI (M). Southern blots of clones 6 and 11 are shown.
Methylation of the MspI-HpaII sites in the GFP
coding region yields a slower-migrating fragment (arrow) in the
HpaII digest lanes. PhosphorImager analysis was performed to
quantitate the DNA in the HpaII-resistant (slower-migrating)
and -sensitive bands. The fraction of the HpaII-resistant
band (no slower-migrating bands were present) over the sum of the
HpaII-resistant and -sensitive bands reflects the degree of
methylation within the hGFP gene. For each sample, this
value is plotted against the day p.i. (d.p.i.) on which genomic DNA was
harvested (Fig. 1). (C) Analysis of the methylation state of the LTR
with the methylation-sensitive enzyme BssHII, which cuts
once in the LTR at the 3' end of the U3 region. Genomic DNA from
MFG-hGFP clones 6, 11, 18, and 19 was digested with
BamHI alone or in combination with BssHII.
Southern blots of clones 11 and 18 are shown. Digestion at the
BamHI and BssHII sites yields a 2,210-bp fragment
(open arrow). The presence of a methyl group at the BssHII
site yields a clone-specific fragment of the same size as that in the
BamHI-alone lane (solid arrow). The fraction of DNA
resistant to BssHII digestion was determined and plotted as
described for the MspI-HpaII digests.
|
|
We generated primers to amplify a 457-bp fragment at the 5' end of the
720-bp hGFP gene. Since the hGFP gene has a very
high density of CpGs (see Discussion), the resulting "allelic"
amplification product yielded information on a total of 127 cytosines,
36 of which were in the context of CpG. Two of these CpGs were within the HpaII sites characterized in the Southern analyses.
Genomic DNA isolated from clones 6, 11, and 18 on days 39 and 78 p.i. was bisulfite treated, amplified, and subcloned. Analysis of the sequenced alleles revealed that the density of mCpGs increased significantly for each clonal population (P < 0.001;
Student's t test). The sample mean increased from 14.6 ± 1.3 to 27.3 ± 0.7 mCpGs for clone 6 (excluding strands in
which only CpNpG methylation was detected; see Discussion) (Fig.
4A), from 19.9 ± 0.8 to 30.3 ± 0.8 for clone 11 (data not shown), and from 8.6 ± 0.9 to
21.6 ± 1.6 for clone 18 (Fig. 4B). This trend confirmed that seen
by Southern analysis and was consistent with the previous observation that the de novo methylation rate is dependent on the site of integration (26). While specific CpGs may be preferentially methylated within a clonal population, no sites were consistently hypermethylated in a clone-to-clone comparison. Taken together with the
data in Fig. 2, these results reveal that during the time when the
provirus becomes refractory to TSA induction, the methylation density
increases significantly, suggesting the involvement of an as yet
uncharacterized methylation density-dependent, histone deacetylation-independent mechanism of transcriptional repression that
acts on proviruses as well as endogenous genes (10).

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 4.
The mCpG density of the hGFP gene increases
with time in culture. Genomic DNA isolated from clones 6 (A) and 18 (B)
at 39 and 78 days p.i. (d.p.i.) was bisulfite treated and amplified in
a seminested reaction with the GFP-specific primer pairs +1870+ plus
+2300 and +1903+ plus +2300 in the first and second rounds,
respectively. Amplified products were ligated, cloned, and sequenced as
described in Materials and Methods. For each genomic sample, at least
two amplification and ligation reactions were carried out. A map of the
amplified region of the hGFP gene is presented at the top of
the figure, including the potentially methylated CpG
(- -) and CCa/tGG (-|) sites, as
well as the HpaII (H) sites analyzed in the Southern
analyses. For each allele, mCpG (- -) and
methylated CC(a/t)GG (-|) sequences are
shown. Presumed nonconverted cytosines ( C ) (cytosines present in
the bisulfite-treated DNA but not originally in the context of CpG or
CpNpG) are also displayed. The number of mCpGs inferred for each allele
and the sample mean ± SEM of each genomic isolate are presented
on the left of the figure. Alleles with CC(a/t)GG
methylation ( ) are also labeled.
|
|
The bisulfite analysis also revealed non-CpG cytosine methylation in
the hGFP gene, particularly of the internal cytosine in the
sequence context CC(a/t)GG (Fig. 4), consistent with the previous description of CpNpG methylation in mammalian cells
(12). This modification was often detected on strands
lacking conventional CpG methylation. CC(a/t)GG is the
recognition site of the E. coli Dcm methylase. Maintenance
of the original methylation pattern of the plasmid transfected into the
Phoenix A retroviral producer cells is unlikely, since the retroviral
genome passes through an RNA intermediate. Furthermore, since the
genomic DNA is bisulfite treated prior to transformation into the
dcm+ E. coli XL-1 Blue strain,
contamination is not a possibility at this step in the procedure.
However, plasmid DNA contamination of the genomic DNA prior to
bisulfite conversion remains a formal possibility. We think that this
explanation is unlikely for two reasons. First, in several alleles, CpG
methylation, which is unique to mammalian cells, coexists with
CC(a/t)GG methylation on the same molecule of DNA. Second,
adenine methylation in the sequence GATC, the recognition site of
E. coli Dam methylase, was not detected: digestion of
MFG-hGFP plasmid DNA isolated from the
dam+ E. coli XL-1 Blue strain with the
methylation-sensitive enzyme MboI showed complete inhibition
of digestion, while Southern blotting of MboI-digested clone
18 genomic DNA isolated 39 days p.i. revealed complete cutting (data
not shown). Interestingly, CC(a/t)GG methylation was
detected primarily in early-passage cells, suggesting that CpNpG
methylation may be an early event in proviral silencing.
Several groups have observed that methylation of the promoter region is
particularly effective in repressing expression (9, 33),
while others report that methylation density, regardless of
localization, is the critical factor in methylation-mediated repression
(6, 27). To study the methylation state of the MFG-hGFP promoter, we used the methylation-sensitive enzyme
BssHII, which cuts once in the proviral LTR (Fig. 3A) just
upstream of the TATA box. As with the HpaII analyses,
BssHII digestion revealed that methylation increased over
time for clones 6, 11, and 18 but remained unchanged or decreased for
clone 19 (Fig. 3C). For each clone, this site was significantly more
methylated at each time point than the HpaII sites analyzed
in the hGFP gene, suggesting that de novo methylation of the
promoter may occur at a higher rate.
To study the methylation state of the enhancer/promoter region at
higher resolution, primers were designed to amplify a 565-bp fragment,
including most of the 5' LTR and the primer binding site. The M-MuLV
enhancer is made up of two direct repeats, which include binding sites
for a number of transcription factors (21) and which, like
many enhancer elements, include few CpGs. In contrast, the downstream
promoter region contains a cluster of CpGs, including the
BssHII site. Bisulfite analysis of clone 6 reveals that the mean number of mCpGs in the 5' LTR increased significantly
(P < 0.001), from 2.5 ± 0.3 at 39 days p.i. to
6.9 ± 0.5 at 78 days p.i. (Fig. 5).
In contrast to the direct-repeat region, which remained
hypomethylated, the promoter region became hypermethylated relative
to flanking DNA.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 5.
The mCpG density of the LTR increases with time in
culture. Clone 6 genomic DNA isolated at 39 and 78 days p.i. (d.p.i.)
was bisulfite treated and amplified in a nested reaction with the
vector-specific primers +25+ and +1080 in the first round and the 5'
LTR-specific primers +58+ and +665 in the second round. A map of the
5' LTR is presented at the top of the figure, including the potentially
methylated CpG (- -) and CCa/tGG
(-|) sites, the locations of the direct repeats
(DR) of the tandem enhancer, the transcription start site, the primer
binding site (PBS), and the BssHII site analyzed in the
Southern analyses. mCpGs (- -) and nonconverted
cytosines ( C ) are shown for each sequenced allele. The number of
mCpGs inferred for each allele and the sample mean ± SEM are
presented on the left of the figure.
|
|
GFP expression in late-passage clones can be induced only by
sequential treatment with 5-azaC followed by TSA.
If the increased
density of proviral mCpGs is responsible for the progressive diminution
of TSA responsiveness, the efficacy of TSA treatment should be
reestablished by reducing proviral methylation. Late-passage clones
(with near-complete extinction of TSA inducibility) were pretreated
with 5-azaC for 24 h and then treated with TSA and 5-azaC for
24 h. Pretreatment with 5-azaC increased the inductive potential
of TSA ~10-fold over that of TSA alone (Fig.
6A). This order of addition is required
for the synergistic effect: pretreatment with TSA, or treatment with
TSA and 5-azaC together for only 24 h, does not potentiate
induction. As with treatment of early-passage clones with either drug
alone, the degree of induction was dependent on the integration site and the fraction of cells induced within each clonal population, greatest for clone 18 and least for clone 11, was inversely related to
the extent of methylation of each clone.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
Pretreatment with 5-azaC potentiates induction of
proviral expression by TSA. (A) MEL MFG-hGFP clones 6, 11, and 18 (101 days p.i.) were treated with 100 nM TSA (T) or 5µM 5-azaC
(5) for 24 h, washed, and treated for a further 24 h either with the same drug or with both TSA and 5-azaC (5+T). At
24 h after the second treatment, the cells were harvested and
prepared for flow cytometry. Results for control untreated cells, as
well as samples treated only on the second day, are also presented. (B)
MEL MFG-hGFP clone 18 cells (108 days p.i.) were treated
with 100 nM TSA or 5 µM 5-azaC for 48 h. The percentage of
GFP-positive cells prior to sorting is shown on the y axis
(Pre-Sort day 0). Viable GFP-positive cells were sorted into complete
medium and immediately reanalyzed by FACS (Post-Sort day 0) to confirm
sorting purity. Sorted cells were washed in fresh complete medium and
replated. Aliquots of the sorted population were removed daily for FACS
analysis. Aliquots of the sorted cultures were treated with TSA on day
5 postsorting and analyzed for GFP expression on days 6 and 7 post-sorting (dotted lines). Each point represents the percentage of
viable cells that were scored as GFP positive. Analyses of MEL parental
cells are included on each day of analysis. (C) Treatment and sorting
as described in panel B was repeated, and triplicate subcultures of
sorted clone 18 and 19 cells were established. Subcultures were
re-treated on day 5 and analyzed on day 6. Each bar represents the mean
percentage of viable cells scored as GFP positive. Error bars show the
standard deviation. For all samples, dead cells were excluded from the
analyses on the basis of PI staining and forward- and side-scatter
parameters.
|
|
If 5-azaC pretreatment potentiates induction by reducing the
methylation density of proviral DNA, then, given the low rate of de
novo methylation, the effect of 5-azaC should persist for some time
after the drug is removed. Late-passage clone 18 cells were treated for
2 days either with 5-azaC or with TSA, and GFP-expressing cells were
sorted to generate homogeneous populations of 5-azaC- or TSA-responsive
cells. Sorted cells were washed, placed in culture, and monitored daily
for GFP expression. Regardless of the inducing agent applied,
retroviral expression is rapidly silenced. However, upon retreatment of
the cultures with TSA 5 days postsorting (by which time >90% of the
cells are silenced), only the cells originally treated with 5-azaC were
effectively induced (Fig. 6B). Repetition of the experiment with sorted
clone 18 and 19 cells showed the same effect (Fig. 6C). For both
clones, the potentiating effect of 5-azaC was still apparent 11 days
postsorting, indicating that alteration of the provirus mediated by
5-azaC extends well beyond the time when the silent state is
reestablished (data not shown).
The results described above are consistent with a model in which
proviral expression becomes refractory to TSA induction as a result of
the accumulation of mCpGs in late-passage cells and in which 5-azaC
treatment of these cells reduces proviral methylation density
sufficiently to allow TSA induction. To explicitly test whether 5-azaC
treatment under the conditions used inhibits maintenance methyltransferase activity and thus demethylates the provirus, subcultures of clone 18 cells at 48 days p.i. were treated with 5 µM
5-azaC for 48 h. Untreated and treated cells were sorted on the
basis of viability alone, and treated viable GFP-positive cells were
also sorted (Fig. 7A). Extracts of each
sorted subpopulation were bisulfite treated and amplified with the
hGFP primer set. In the absence of 5-azaC treatment, a mean
of 17.8 ± 0.9 mCpGs were present in this region of the
hGFP gene, within range of the predicted value from the
initial time course experiment (Fig. 4A). No decrease in the number of
mCpGs (20.3 ± 0.6) was detected in the cell population sorted on
the basis of viability alone, indicating that in the majority of
5-azaC-treated cells, the hGFP gene is not demethylated
(Fig. 7B). Given that GFP expression was induced in only 21% of these
cells, this result is not surprising. In contrast, the 5-azaC-treated
population sorted on the basis of GFP expression showed a significant
decrease in hGFP methylation (P = 0.027), to
a mean of 13.3 ± 1.7 mCpGs. The decrease in the number of mCpGs
resulted primarily from the appearance of several alleles with very low
levels of methylation, from 1 to 9 mCpGs/molecule (Fig. 7B). Given the
duration of 5-azaC treatment in this experiment, the presence of
alleles with higher mCpG density in the GFP-positive population is not
surprising: since 5-azaC inhibits methylation during DNA replication,
only the nascent strand in daughter cells is unmethylated. Such
hemimethylated DNA is a poor substrate for the MeCP complexes (38,
41) and thus may adopt a chromatin state permissive for
expression. The bisulfite sequencing assay yielded data on only one
strand and therefore cannot be used to reveal the methylation status of
complementary strands. Given that only 1% of the cells were GFP
positive in the untreated sample, we conclude that 5-azaC-mediated
proviral induction is strongly correlated with decreased local
methylation density. Similar results were found for clone 6 (data not
shown), and, as with the time course study, CC(a/t)GG
methylation was also detected in the 5-azaC-treated samples. These
results are consistent with the hypothesis that 5-azaC treatment of
late-passage clones potentiates TSA-mediated GFP expression by reducing
proviral methylation density and help to explain why the efficacy of
5-azaC treatment diminishes with time; the duration of treatment and
concentration of drug used are not sufficient to fully demethylate the
provirus.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 7.
Induction of GFP expression by 5-azaC treatment is
correlated with partial demethylation of the hGFP gene.
Subcultures of clone 18 cells (48 days p.i.) were treated with 5 µM
5-azaC for 48 h. Subsequently, mock-treated and 5-azaC-treated
cells were FACS sorted on the basis of PI staining alone (Pot Sort),
and 5-azaC-treated, viable GFP-positive cells were also sorted. Each
sorted sample was immediately lysed and subjected to bisulfite
conversion. (A) For each population, 5% probability plots are shown.
The electronic gate used to sort GFP-positive cells from the
5-azaC-treated population is also shown. The percentage of GFP-positive
cells in each population is shown at the top of each plot.
Amplification, cloning, and sequencing were conducted as described in
the legend to Fig. 4 and Materials and Methods. (B) Map of the
amplified region of the hGFP gene, including the potentially
methylated CpG (- -) and CCa/tGG
(-|) sites. For each allele, mCpG
(- -), methylated CC(a/t)GG sequences
(-|), and presumed nonconverted cytosines ( C )
are shown. The number of mCpGs inferred for each allele and the sample
mean ± SEM of each sorted population is presented on the left of
the figure. Alleles with relatively low levels of methylation (*)
(<10 mCpGs) and/or CC(a/t)GG methylation ( ) are
labeled accordingly.
|
|
 |
DISCUSSION |
The infected cells characterized in this study contain a provirus
that is silenced at the earliest time point analyzed, 5 days p.i.
Bisulfite analysis of the hGFP gene in the subpopulation of
MFG-hGFP infected cells not expressing GFP revealed that the provirus was methylated by day 11 p.i., the earliest time point studied (data not shown). The mean density of 2.6 ± 0.4 mCpGs/100 bp is within the range of the mCpG density at which the repressor MeCP2
effectively inhibits expression in vitro (>1 mCpG/100 bp) (42), indicating that the inductive effect of TSA may result from inhibition of HDAC-MeCP2 complexes associated with nascent mCpGs
(17, 30, 43). Others have proposed that transcriptional repression precedes de novo methylation (20, 45), and we
cannot rule out the possibility that HDACs are recruited to the nascent provirus by a mCpG-independent mechanism. For example, a
sequence-specific DNA binding factor such as YY-1, which binds to a
conserved region within the M-MuLV LTR (18) and is known to
recruit an HDAC-associated complex (59), may play a role in
repressing proviral expression. Alternatively, constitutively
methylated flanking DNA may contribute to repression of the nascent
provirus; for example, it has been reported that methylated DNA can
silence an adjacent unmethylated promoter (31).
Regardless of the mechanism initiating transcriptional silencing,
expression of the nascent provirus can be induced by treatment with
TSA, consistent with several reports showing that inhibition of HDAC
activity is sufficient to activate otherwise nonexpressing transgenes
(11, 46, 56). However, in vitro methylation studies of an
episomal reporter construct revealed that the efficacy of transcriptional induction by sodium butyrate is inversely related to
methylation density (27), suggesting the presence of an
HDAC-independent, methylation density-dependent repressive mechanism.
We found that with increasing time in culture, the efficacy of
TSA-mediated proviral induction diminished, to an extent dependent upon
the proviral integration site. These results contrast with a previous report (11) of no diminution of TSA responsiveness of an
rAAV/CMVlacZ reporter in HeLa cells. This discrepancy may be explained
by the difference in enhancers or experimental conditions used. The
concentration of TSA used in the study described in reference
11, 3,000 nM, yields significant cytotoxicity in MEL
cells (M. Lorincz, unpublished observation).
The hGFP reporter and the E. coli lacZ gene have
CpG densities of ~9/100 bp. Although this CpG density is also
comparable to that of endogenous genes, such as human
-globin
(2), the majority of CpGs in hGFP were introduced
during the codon optimization process (23) and thus may not
reflect the normal distribution of CpGs in mammalian genes. The failure
of TSA-mediated induction, however, is not peculiar to the
hGFP reporter, since we observed a similar time-dependent
diminution of drug induction when we replaced hGFP with the
murine CD8
gene (4 CpGs/100 bp) in the MFG vector (data
not shown). These observations have important implications for gene
therapy protocols: given that TSA treatment yields only transitory
expression of provirus methylated at low density (Fig. 6) and is
completely ineffective in inducing the expression of highly methylated
provirus, it is unlikely that TSA treatment to relieve suppression of
therapeutic retroviral vectors will improve gene therapy for genetic
diseases (11). Development of vectors which are refractory
to de novo methylation should be a more efficacious approach
(49).
To generate the TSA-inducible M-MuLV-hGFP MEL
clones characterized in this study, infected cells were subject
to TSA treatment and cell sorting on the basis of GFP expression.
Subsequently, the clones were split weekly and only those subcultures
to be screened for inducibility that week were treated with TSA or
5-azaC. Nevertheless, since TSA has pleiotropic effects on cells
(60), we cannot rule out the possibility that the initial
TSA treatment induced trans effects, such as alteration of
the transcription factor milieu. We think that this explanation is
unlikely, since infection of a late-passage (noninducible) MEL
MFG-hGFP clone with MFG-CD8 yielded a
subpopulation of cells expressing CD8 at levels comparable to those in
MEL cells infected with MFG-CD8 alone (data not shown). That
the complement of trans-acting factors necessary for
expression from the M-MuLV enhancer are present and functional in these
cells indicates that the progressive loss of responsiveness to TSA and
5-azaC results from a cis-mediated alteration of the provirus.
The bisulfite and Southern blot data reveals that the methylation
density gradually increases in both the hGFP gene and the LTR with time in culture. However, the fraction of CpGs methylated in
the hGFP gene (0.58 to 0.83) is clearly greater than that in the LTR (0.08 to 0.37) by day 88 p.i. At first impression, this observation contradicts that seen in the Southern analysis experiments, but closer inspection of the bisulfite data reveals that the 3' HpaII site in the hGFP gene is hypomethylated
compared with flanking CpGs and that the BssHII site in the
LTR is hypermethylated compared to flanking CpGs. This data clearly
illustrates that, given the heterogeneity in methylation of specific
CpGs, the use of single sites to study methylation patterns can yield
misleading results. The enhancer region, in particular, remains devoid
of mCpGs, perhaps as a result of passive inhibition by transcription
factor binding (40) or recruitment of a demethylating factor
(39). Nevertheless, as previously shown for the simian virus
40 enhancer (6), the methylation-free M-MuLV enhancer is
clearly insufficient to induce expression when the density of mCpGs in
cis exceeds a certain threshold. In contrast to the
enhancer, the promoter/cap site region became heavily methylated with
time in culture. Several studies show that methylation of the
promoter/preinitiation domain is sufficient to repress gene expression
(47), perhaps by recruitment of methyl-binding proteins,
such as MeCP1 (5, 51), which might inhibit the formation of
the preinitiation complex (36). Such transcriptional
repression may operate independently of HDAC activity, thus explaining
the loss of TSA-mediated induction in late-passage cells.
Unfortunately, given that the promoter region and the hGFP
gene are de novo methylated concurrently, we cannot attribute the
HDAC-independent repressive effect to methylation of a specific region
in the provirus.
The GFP-based reporter system described here allowed a coordinated
analysis of the transcriptional induction and methylation status of
single proviral integrants at successive time points after infection.
These experiments clearly revealed a diminution of TSA induction
concomitant with the accumulation of proviral mCpGs during serial
passage. Interestingly, de novo methylation continued to occur long
after the provirus was silenced. Southern analysis of genomic DNA
isolated from TSA-treated cultures revealed no reduction in proviral
methylation in cells in which GFP expression was induced, suggesting
that TSA does not act as a demethylating agent (reference
17 and data not shown). The observation that 5-azaC
treatment only partially demethylates the provirus helps to explain why
the efficacy of treatment with this drug also diminishes with time;
residual methylation is probably sufficient to maintain MeCP2- and
HDAC-mediated silencing in late-passage cells. Expression is inducible
in such late-passage cells only by treatment with 5-azaC followed by
TSA. These results are consistent with those recently reported by
Cameron et al. (10), who found that several hypermethylated
endogenous genes could be reactivated only by treatment with 5-azaC
followed by TSA. Taken together, these experiments reveal that HDAC
activity is the primary effector of repression mediated by low-density
methylation whereas an as yet uncharacterized HDAC-independent
mechanism predominates in the repression of highly methylated genes.
MBD proteins (24, 43), MeCP2-associated proteins such as
mSin3 (35), or chromatin-specific proteins such as histone H1 (37) may be involved in such repression. MBD1 is a
particularly intriguing candidate, since it lacks the MeCP2 TRD
(24) required for binding to the Sin3-histone deacetylase
complex. Interestingly, the MBD1 protein includes the CxxCxxC motif
found in several mammalian proteins, including ALL-1/HRX, which is
related to Drosophila trithorax (15), suggesting
the potential involvement of the trithorax/polycomb protein groups in
methylation-mediated repression. The MeCP1 complex may also be
involved, since, in contrast to MeCP2 (38), it binds
efficiently only to substrates containing an array of mCpGs (5,
41). The binding of MBD proteins may promote the recruitment of
densely methylated provirus to a repressive nuclear compartment, such
as centromeric heterochromatin foci (7). Whatever the
mechanism, when a threshold of local methylation density is reached,
~5 mCpGs/100 bp depending on the integration site, the provirus may
become irreversibly silenced. Our time course experiments revealed the
dynamic nature of methylation-mediated repression of a nascent
provirus, with HDAC activity playing the predominant role early after
infection and an HDAC-independent mechanism consolidating the silent
state. Clearly, further characterization of methylation-mediated
repression will require that mCpG density be taken into account.
 |
ACKNOWLEDGMENTS |
The GFP-Bex1 plasmid and Phoenix A retroviral producer cells were
kind gifts of M. Anderson and G. Nolan, respectively. We thank Claire
Francastel, Robert Eisenman, Steve Fiering, Reinhard Stoeger, Dan
Cimbora, and the Martin and Groudine laboratories for helpful
suggestions. We also thank the FHCRC Biotechnology and Flow Cytometry
Shared Resource facilities for technical assistance and Kristy Seidel
for advice on statistical analysis.
This work was supported by NIH grants to M.G. and D.I.K.M., who is a
Scholar of the Leukemia Society of America, and fellowships from the
NIH to M.C.L. and Deutsche Forschungsgemeinschaft to D.S.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview
Ave. North, Mailstop A3-025, Seattle, WA 98109-1024. Phone: (206)
667-4492. Fax: (206) 667-5894. E-mail: mlorincz{at}fhcrc.org.
Present address: Victor Chang Cardiac Research Institute,
Darlinghurst, Sydney, NSW 2010, Australia.
 |
REFERENCES |
| 1.
|
Anderson, M. T.,
I. M. Tjioe,
M. C. Lorincz,
D. R. Parks,
L. A. Herzenberg,
G. P. Nolan, and L. A. Herzenberg.
1996.
Simultaneous fluorescence-activated cell sorter analysis of two distinct transcriptional elements within a single cell using engineered green fluorescent proteins.
Proc. Natl. Acad. Sci. USA
93:8508-8511[Abstract/Free Full Text].
|
| 2.
|
Antequera, F., and A. Bird.
1993.
Number of CpG islands and genes in human and mouse.
Proc. Natl. Acad. Sci. USA
90:11995-11999[Abstract/Free Full Text].
|
| 3.
|
Bahnson, A. B.,
J. T. Dunigan,
B. E. Baysal,
T. Mohney,
R. W. Atchison,
M. T. Nimgaonkar,
E. D. Ball, and J. A. Barranger.
1995.
Centrifugal enhancement of retroviral mediated gene transfer.
J. Virol. Methods
54:131-143[CrossRef][Medline].
|
| 4.
|
Bartsch, J.,
M. Truss,
J. Bode, and M. Beato.
1996.
Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure.
Proc. Natl. Acad. Sci. USA
93:10741-10746[Abstract/Free Full Text].
|
| 5.
|
Boyes, J., and A. Bird.
1991.
DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein.
Cell
64:1123-1134[CrossRef][Medline].
|
| 6.
|
Boyes, J., and A. Bird.
1992.
Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein.
EMBO J.
11:327-333[Medline].
|
| 7.
|
Brown, K. E.,
S. S. Guest,
S. T. Smale,
K. Hahm,
M. Merkenschlager, and A. G. Fisher.
1997.
Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin.
Cell
91:845-854[CrossRef][Medline].
|
| 8.
|
Buschhausen, G.,
B. Wittig,
M. Graessmann, and A. Graessmann.
1987.
Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene.
Proc. Natl. Acad. Sci. USA
84:1177-1181[Abstract/Free Full Text].
|
| 9.
|
Busslinger, M.,
J. Hurst, and R. A. Flavell.
1983.
DNA methylation and the regulation of globin gene expression.
Cell
34:197-206[CrossRef][Medline].
|
| 10.
|
Cameron, E. E.,
K. E. Bachman,
S. Myohanen,
J. G. Herman, and S. B. Baylin.
1999.
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Nat. Genet.
21:103-107[CrossRef][Medline].
|
| 11.
|
Chen, W. Y.,
E. C. Bailey,
S. L. McCune,
J. Y. Dong, and T. M. Townes.
1997.
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.
Proc. Natl. Acad. Sci. USA
94:5798-5803[Abstract/Free Full Text].
|
| 12.
|
Clark, S. J.,
J. Harrison, and M. Frommer.
1995.
CpNpG methylation in mammalian cells.
Nat. Genet.
10:20-27[CrossRef][Medline].
|
| 13.
|
Clark, S. J.,
J. Harrison,
C. L. Paul, and M. Frommer.
1994.
High sensitivity mapping of methylated cytosines.
Nucleic Acids Res.
22:2990-2997[Abstract/Free Full Text].
|
| 14.
|
Coffee, B.,
F. Zhang,
S. T. Warren, and D. Reines.
1999.
Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.
Nat. Genet.
22:98-101[CrossRef][Medline]. (Erratum, 22:209.)
|
| 15.
|
Cross, S. H.,
R. R. Meehan,
X. Nan, and A. Bird.
1997.
A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins.
Nat. Genet.
16:256-259[CrossRef][Medline].
|
| 16.
|
Dranoff, G.,
E. Jaffee,
A. Lazenby,
P. Golumbek,
H. Levitsky,
K. Brose,
V. Jackson,
H. Hamada,
D. Pardoll, and R. C. Mulligan.
1993.
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
Proc. Natl. Acad. Sci. USA
90:3539-3543[Abstract/Free Full Text].
|
| 17.
|
Eden, S.,
T. Hashimshony,
I. Keshet,
H. Cedar, and A. W. Thorne.
1998.
DNA methylation models histone acetylation.
Nature
394:842[CrossRef][Medline].
|
| 18.
|
Flanagan, J. R.,
K. G. Becker,
D. L. Ennist,
S. L. Gleason,
P. H. Driggers,
B. Z. Levi,
E. Appella, and K. Ozato.
1992.
Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus.
Mol. Cell. Biol.
12:38-44[Abstract/Free Full Text].
|
| 19.
|
Frommer, M.,
L. E. McDonald,
D. S. Millar,
C. M. Collis,
F. Watt,
G. W. Grigg,
P. L. Molloy, and C. L. Paul.
1992.
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.
Proc. Natl. Acad. Sci. USA
89:1827-1831[Abstract/Free Full Text].
|
| 20.
|
Gautsch, J. W., and M. C. Wilson.
1983.
Delayed de novo methylation in teratocarcinoma suggests additional tissue-specific mechanisms for controlling gene expression.
Nature
301:32-37[CrossRef][Medline].
|
| 21.
|
Granger, S. W., and H. Fan.
1998.
In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
J. Virol.
72:8961-8970[Abstract/Free Full Text].
|
| 22.
|
Groudine, M.,
R. Eisenman, and H. Weintraub.
1981.
Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation.
Nature
292:311-317[Medline].
|
| 23.
|
Haas, J.,
E. C. Park, and B. Seed.
1996.
Codon usage limitation in the expression of HIV-1 envelope glycoprotein.
Curr. Biol.
6:315-324[CrossRef][Medline].
|
| 24.
|
Hendrich, B., and A. Bird.
1998.
Identification and characterization of a family of mammalian methyl-CpG binding proteins.
Mol. Cell. Biol.
18:6538-6547[Abstract/Free Full Text].
|
| 25.
|
Hitoshi, Y.,
J. Lorens,
S. I. Kitada,
J. Fisher,
M. LaBarge,
H. Z. Ring,
U. Francke,
J. C. Reed,
S. Kinoshita, and G. P. Nolan.
1998.
Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
Immunity
8:461-471[CrossRef][Medline].
|
| 26.
|
Hoeben, R. C.,
A. A. Migchielsen,
R. C. van der Jagt,
H. van Ormondt, and A. J. van der Eb.
1991.
Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.
J. Virol.
65:904-912[Abstract/Free Full Text].
|
| 27.
|
Hsieh, C. L.
1994.
Dependence of transcriptional repression on CpG methylation density.
Mol. Cell. Biol.
14:5487-5494[Abstract/Free Full Text].
|
| 28.
|
Humphries, E. H.,
R. Allen, and C. Glover.
1981.
Clonal analysis of the integration and expression of endogenous avian retroviral DNA acquired by exogenous viral infection.
J. Virol.
39:584-596[Abstract/Free Full Text].
|
| 29.
|
Jahner, D.,
H. Stuhlmann,
C. L. Stewart,
K. Harbers,
J. Lohler,
I. Simon, and R. Jaenisch.
1982.
De novo methylation and expression of retroviral genomes during mouse embryogenesis.
Nature
298:623-628[CrossRef][Medline].
|
| 30.
|
Jones, P. L.,
G. J. Veenstra,
P. A. Wade,
D. Vermaak,
S. U. Kass,
N. Landsberger,
J. Strouboulis, and A. P. Wolffe.
1998.
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
Nat. Genet.
19:187-191[CrossRef][Medline].
|
| 31.
|
Kass, S. U.,
N. Landsberger, and A. P. Wolffe.
1997.
DNA methylation directs a time-dependent repression of transcription initiation.
Curr. Biol.
7:157-165[CrossRef][Medline].
|
| 32.
|
Keshet, I.,
J. Lieman-Hurwitz, and H. Cedar.
1986.
DNA methylation affects the formation of active chromatin.
Cell
44:535-543[CrossRef][Medline].
|
| 33.
|
Keshet, I.,
J. Yisraeli, and H. Cedar.
1985.
Effect of regional DNA methylation on gene expression.
Proc. Natl. Acad. Sci. USA
82:2560-2564[Abstract/Free Full Text].
|
| 34.
|
Kudo, S.
1998.
Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated.
Mol. Cell. Biol.
18:5492-5499[Abstract/Free Full Text].
|
| 35.
|
Laherty, C. D.,
W. M. Yang,
J. M. Sun,
J. R. Davie,
E. Seto, and R. N. Eisenman.
1997.
Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression.
Cell
89:349-356[CrossRef][Medline].
|
| 36.
|
Levine, A.,
G. L. Cantoni, and A. Razin.
1992.
Methylation in the preinitiation domain suppresses gene transcription by an indirect mechanism.
Proc. Natl. Acad. Sci. USA
89:10119-10123[Abstract/Free Full Text].
|
| 37.
|
Levine, A.,
A. Yeivin,
E. Ben-Asher,
Y. Aloni, and A. Razin.
1993.
Histone H1-mediated inhibition of transcription initiation of methylated templates in vitro.
J. Biol. Chem.
268:21754-21759[Abstract/Free Full Text].
|
| 38.
|
Lewis, J. D.,
R. R. Meehan,
W. J. Henzel,
F. I. Maurer,
P. Jeppesen,
F. Klein, and A. Bird.
1992.
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.
Cell
69:905-914[CrossRef][Medline].
|
| 39.
|
Lichtenstein, M.,
G. Keini,
H. Cedar, and Y. Bergman.
1994.
B cell-specific demethylation: a novel role for the intronic kappa chain enhancer sequence.
Cell
76:913-923[CrossRef][Medline].
|
| 40.
|
Matsuo, K.,
J. Silke,
O. Georgiev,
P. Marti,
N. Giovannini, and D. Rungger.
1998.
An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA.
EMBO J.
17:1446-1453[CrossRef][Medline].
|
| 41.
|
Meehan, R. R.,
J. D. Lewis,
S. McKay,
E. L. Kleiner, and A. P. Bird.
1989.
Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs.
Cell
58:499-507[CrossRef][Medline].
|
| 42.
|
Nan, X.,
F. J. Campoy, and A. Bird.
1997.
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
Cell
88:471-481[CrossRef][Medline].
|
| 43.
|
Nan, X.,
H. H. Ng,
C. A. Johnson,
C. D. Laherty,
B. M. Turner,
R. N. Eisenman, and A. Bird.
1998.
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
Nature
393:386-389[CrossRef][Medline].
|
| 44.
|
Niwa, O., and T. Sugahara.
1981.
5-Azacytidine induction of mouse endogenous type C virus and suppression of DNA methylation.
Proc. Natl. Acad. Sci. USA
78:6290-6294[Abstract/Free Full Text].
|
| 45.
|
Niwa, O.,
Y. Yokota,
H. Ishida, and T. Sugahara.
1983.
Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells.
Cell
32:1105-1113[CrossRef][Medline].
|
| 46.
|
Pikaart, M. J.,
F. Recillas-Targa, and G. Felsenfeld.
1998.
Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators.
Genes Dev.
12:2852-2862[Abstract/Free Full Text].
|
| 47.
|
Razin, A., and H. Cedar.
1991.
DNA methylation and gene expression.
Microbiol. Rev.
55:451-458[Abstract/Free Full Text].
|
| 48.
|
Riggs, M. G.,
R. G. Whittaker,
J. R. Neumann, and V. M. Ingram.
1977.
n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells.
Nature
268:462-464[CrossRef][Medline].
|
| 49.
|
Robbins, P. B.,
D. C. Skelton,
X. J. Yu,
S. Halene,
E. H. Leonard, and D. B. Kohn.
1998.
Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.
Proc. Natl. Acad. Sci. USA
95:10182-10187[Abstract/Free Full Text].
|
| 50.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Plainview, N.Y.
|
| 51.
|
Singal, R.,
R. Ferris,
J. A. Little,
S. Z. Wang, and G. D. Ginder.
1997.
Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells.
Proc. Natl. Acad. Sci. USA
94:13724-13729[Abstract/Free Full Text].
|
| 52.
|
Smith, C. L., and G. L. Hager.
1997.
Transcriptional regulation of mammalian genes in vivo. A tale of two templates.
J. Biol. Chem.
272:27493-27496[Free Full Text].
|
| 53.
|
Stewart, C. L.,
H. Stuhlmann,
D. Jahner, and R. Jaenisch.
1982.
De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells.
Proc. Natl. Acad. Sci. USA
79:4098-4102[Abstract/Free Full Text].
|
| 54.
|
Struhl, K.
1998.
Histone acetylation and transcriptional regulatory mechanisms.
Genes Dev.
12:599-606[Free Full Text].
|
| 55.
|
Stuhlmann, H.,
D. Jahner, and R. Jaenisch.
1981.
Infectivity and methylation of retroviral genomes is correlated with expression in the animal.
Cell
26:221-232[CrossRef][Medline].
|
| 56.
|
Van Lint, C.,
S. Emiliani,
M. Ott, and E. Verdin.
1996.
Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.
EMBO J.
15:1112-1120[Medline].
|
| 57.
|
Weintraub, H.
1985.
Assembly and propagation of repressed and depressed chromosomal states.
Cell
42:705-711[CrossRef][Medline].
|
| 58.
|
Xu, L.,
J. K. Yee,
J. A. Wolff, and T. Friedmann.
1989.
Factors affecting long-term stability of Moloney murine leukemia virus-based vectors.
Virology
171:331-341[CrossRef][Medline].
|
| 59.
|
Yang, W. M.,
C. Inouye,
Y. Zeng,
D. Bearss, and E. Seto.
1996.
Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3.
Proc. Natl. Acad. Sci. USA
93:12845-12850 |